169 related articles for article (PubMed ID: 15668802)
1. Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone--an acute study in rats.
Hu LW; Liberti EA; Barreto-Chaves ML
Virchows Arch; 2005 Mar; 446(3):265-9. PubMed ID: 15668802
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and cardiac paracrine actions of insulin-like growth factor-I (IGF-I) during thyroid dysfunction in the rat: is IGF-I implicated in the mechanism of heart weight/body weight change during abnormal thyroid function?
Thomas MR; Miell JP; Taylor AM; Ross RJ; Arnao JR; Jewitt DE; McGregor AM
J Mol Endocrinol; 1993 Jun; 10(3):313-23. PubMed ID: 8373515
[TBL] [Abstract][Full Text] [Related]
3. Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling.
Hu LW; Benvenuti LA; Liberti EA; Carneiro-Ramos MS; Barreto-Chaves ML
Am J Physiol Regul Integr Comp Physiol; 2003 Dec; 285(6):R1473-80. PubMed ID: 12933361
[TBL] [Abstract][Full Text] [Related]
4. Early cardiac hypertrophy induced by thyroxine is accompanied by an increase in VEGF-A expression but not by an increase in capillary density.
Anjos-Ramos L; Carneiro-Ramos MS; Diniz GP; Martins-Silva J; Barreto-Chaves ML
Virchows Arch; 2006 Apr; 448(4):472-9. PubMed ID: 16440199
[TBL] [Abstract][Full Text] [Related]
5. Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats.
Asahi T; Shimabukuro M; Oshiro Y; Yoshida H; Takasu N
Thyroid; 2001 Nov; 11(11):1009-15. PubMed ID: 11762709
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Pflugers Arch; 2007 Apr; 454(1):75-81. PubMed ID: 17206447
[TBL] [Abstract][Full Text] [Related]
7. Clofibrate prevents and reverses the hemodynamic manifestations of hyperthyroidism in rats.
Rodríguez-Gómez I; Cruz A; Moreno JM; Soler A; Osuna A; Vargas F
Am J Hypertens; 2008 Mar; 21(3):341-7. PubMed ID: 18219302
[TBL] [Abstract][Full Text] [Related]
8. Temporal and topographic ultrastructural alterations of rat heart myofibrils caused by thyroid hormone.
Ferreira PJ; L'Abbate C; Abrahamsohn PA; Gouveia CA; Moriscot AS
Microsc Res Tech; 2003 Dec; 62(5):451-9. PubMed ID: 14601151
[TBL] [Abstract][Full Text] [Related]
9. [Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats].
Basset A; Blanc J; Elghozi JL
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):905-10. PubMed ID: 10989728
[TBL] [Abstract][Full Text] [Related]
10. Effect of altered thyroid status on in vitro cardiac performance in rats.
McDonough KH; Chen V; Spitzer JJ
Am J Physiol; 1987 Apr; 252(4 Pt 2):H788-95. PubMed ID: 3565593
[TBL] [Abstract][Full Text] [Related]
11. Salt sensitivity in experimental thyroid disorders in rats.
Perez-Abud R; Rodríguez-Gómez I; Villarejo AB; Moreno JM; Wangensteen R; Tassi M; O'Valle F; Osuna A; Vargas F
Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E281-7. PubMed ID: 21521719
[TBL] [Abstract][Full Text] [Related]
12. Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats.
Moreno JM; Rodríguez Gómez I; Wangensteen R; Osuna A; Bueno P; Vargas F
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E776-83. PubMed ID: 15941780
[TBL] [Abstract][Full Text] [Related]
13. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
Brittsan AG; Kiss E; Edes I; Grupp IL; Grupp G; Kranias EG
J Mol Cell Cardiol; 1999 Sep; 31(9):1725-37. PubMed ID: 10471356
[TBL] [Abstract][Full Text] [Related]
14. Effects of thyroid hormones on the lymphocyte phenotypes in rats: changes in lymphocyte subsets related to thyroid function.
Ohashi H; Itoh M
Endocr Regul; 1994 Sep; 28(3):117-23. PubMed ID: 7858242
[TBL] [Abstract][Full Text] [Related]
15. Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism.
Carneiro-Ramos MS; Diniz GP; Almeida J; Vieira RL; Pinheiro SV; Santos RA; Barreto-Chaves ML
J Physiol; 2007 Aug; 583(Pt 1):213-23. PubMed ID: 17540701
[TBL] [Abstract][Full Text] [Related]
16. Early ultrastructural changes in the myocardium following thyroxine-induced hypertrophy.
Craft-Cormney C; Hansen JT
Virchows Arch B Cell Pathol Incl Mol Pathol; 1980; 33(3):267-73. PubMed ID: 6110274
[TBL] [Abstract][Full Text] [Related]
17. Microtubule reorganization is related to rate of heart myocyte hypertrophy in rat.
Samuel JL; Marotte F; Delcayre C; Rappaport L
Am J Physiol; 1986 Dec; 251(6 Pt 2):H1118-25. PubMed ID: 2947475
[TBL] [Abstract][Full Text] [Related]
18. Alterations in adult rat heart after neonatal dexamethasone therapy.
de Vries WB; van der Leij FR; Bakker JM; Kamphuis PJ; van Oosterhout MF; Schipper ME; Smid GB; Bartelds B; van Bel F
Pediatr Res; 2002 Dec; 52(6):900-6. PubMed ID: 12438668
[TBL] [Abstract][Full Text] [Related]
19. Extract of Lycopus europaeus L. reduces cardiac signs of hyperthyroidism in rats.
Vonhoff C; Baumgartner A; Hegger M; Korte B; Biller A; Winterhoff H
Life Sci; 2006 Feb; 78(10):1063-70. PubMed ID: 16150466
[TBL] [Abstract][Full Text] [Related]
20. Effects of Arginase Inhibition in Hypertensive Hyperthyroid Rats.
Rodríguez-Gómez I; Manuel Moreno J; Jimenez R; Quesada A; Montoro-Molina S; Vargas-Tendero P; Wangensteen R; Vargas F
Am J Hypertens; 2015 Dec; 28(12):1464-72. PubMed ID: 25907224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
